Christopher B. Primiano
2017
In 2017, Christopher B. Primiano earned a total compensation of $1.4M as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 115% increase compared to previous year.
Compensation breakdown
| Bonus | $31,500 |
|---|---|
| Non-Equity Incentive Plan | $133,770 |
| Option Awards | $876,811 |
| Salary | $390,000 |
| Other | $11,460 |
| Total | $1,443,541 |
Primiano received $876.8K in option awards, accounting for 61% of the total pay in 2017.
Primiano also received $31.5K in bonus, $133.8K in non-equity incentive plan, $390K in salary and $11.5K in other compensation.
Rankings
In 2017, Christopher B. Primiano's compensation ranked 7,191st out of 14,666 executives tracked by ExecPay. In other words, Primiano earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,191 out of 14,666 | 51st |
Division Manufacturing | 2,674 out of 5,772 | 54th |
Major group Chemicals And Allied Products | 873 out of 2,075 | 58th |
Industry group Drugs | 681 out of 1,731 | 61st |
Industry Pharmaceutical Preparations | 534 out of 1,333 | 60th |
Source: SEC filing on April 27, 2018.
Primiano's colleagues
We found two more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2017.